Published in Women's Health Weekly, May 15th, 2006
According to researchers in the United States, "The vertebral fracture status of women with osteoporosis has strong prognostic implications that may influence clinical decisions. We developed a simple method for estimating the probability that a new vertebral fracture has occurred in postmenopausal women with osteoporosis."
"Data was from the placebo groups of the Fracture Prevention Trial (median observation=21 months) and the MORE Trial at 2 years," reported J.H. Krege and colleagues of Eli Lilly & Company. "A logistic regression analysis identified prior...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.